The Valley Desk

NCT05263050 · Interventional trial

Trial of an Alternative Cabozantinib Dosing Schedule in Metastatic Renal Cell Carcinoma and Neuroendocrine Tumors

Overall registry status Recruiting

Phase 2

Conditions Carcinoid Tumor, Clear-cell Metastatic Renal Cell Carcinoma, Metastatic Renal Cell Carcinoma, Neuroendocrine Tumors

Delaware Valley sites

First posted

Registry updated

Added to the directory

View this study on ClinicalTrials.gov